What's Happening

Stay up to date on conferences, social posts, and what’s new with Healthesystems

Events

Let’s connect at one of our upcoming conferences or speaking engagements

MedMonitor

An up-to-date timeline of FDA approvals that could impact workers' comp
View All MedMonitor Information

Zavzpret (zavegepant) nasal spray

Approval Date: Mar 2023

Note: New Product

Indicated for the acute treatment of migraine with or without aura

hello world!

Combogesic® (acetaminophen and ibuprofen) tablets

Approval Date: Mar 2023

Note: New Product

Indicated for the short term management of mild to moderate acute pain

hello world!

Trokendi XR (topiramate) extended-release capsules

Approval Date: Feb 2023

Note: First-Time Generic

Indicated for the treatment of partial-onset or primary generalized tonic-clonic seizures, adjunctive therapy for partial-onset, primary generalized tonic-clonic seizures, seizures associated with Lennox-Gastaut syndrome (LGS), and preventive treatment of migraine

hello world!

Advil Dual Action (acetaminophen and ibuprofen) tablets (OTC)

Approval Date: Feb 2023

Note: First-Time Generic

Temporarily relieves minor aches and pains due to headache, toothache, backache, menstrual cramps, muscular aches, minor pain of arthritis

hello world!

Leqembi (lecnemab-irmb) injection

Approval Date: Jan 2023

Note: New Product

Indicated for the treatment of Alzheimer’s in patients with mild cognitive impairment or mild dementia sage of the disease

hello world!

Sunlenca® (lenacapavir) tablets

Approval Date: Dec 2022

Note: New Product

In combination with other antiretrovirals, this drugs is indicated for treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug resistant HIV-1 infection

hello world!

Idacio® (adalimumab-aacf) injection

Approval Date: Dec 2022

Note: New Product

Indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and plaque psoriasis

hello world!

Tzield® (teplizumab-mzwv) injection

Approval Date: Nov 2022

Note: New Product

A first-in-class medication, this drug is indicated to delay the onset of Stage 3 type 1 diabetes, potentially delaying the clinical diagnosis of type 1 diabetes to provide patients with months to years without the burdens of disease.

hello world!

Daliresp® (roflumilast) tablets

Approval Date: Sep 2022

Note: First-Time Generic

Indicated to reduce the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations

hello world!

Tazorac® (tazarotene) gel

Approval Date: Sep 2022

Note: First-Time Generic

Indicated for the topical treatment of plaque psoriasis of up to 20% body surface area involvement

hello world!

Social Hub

Check out our latest posts and activity
View All Social Media
    lockenvelopephone-handsetmagnifiermenucross-circle